Find all
associated with


Refine your query (more in Advanced-Search):
 Focus on the recent 5 years   Focus on the current year   Focus on the last 30 days   More choices ...
 Focus on articles with free fulltexts   More choices ...
 Do simple 'keyword' search (no query expansion)

[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 10 of about 116347
1. Javanmard B, Hassanzadeh Haddad A, Yaghoobi M, Lotfi B: Diode laser ablation of prostate and channel transurethral resection of prostate in patients with prostate cancer and bladder outlet obstruction symptoms. Urol J; 2014 Jul-Aug;11(4):1788-92
MedlinePlus Health Information. consumer health - Prostate Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diode laser ablation of prostate and channel transurethral resection of prostate in patients with prostate cancer and bladder outlet obstruction symptoms.
  • PURPOSE: To evaluate the efficacy of diode laser ablation of prostate for treating lower urinary tract symptoms (LUTS) in patients with locally advanced prostate cancer and comparing results with palli­ative transurethral resection of prostate (pTURP).
  • MATERIALS AND METHODS: Thirty-six known cases of locally advanced prostate cancer with a maximum urinary flow rate (Qmax) of 12 mL per second or less and an International Prostate Symptom Score (IPSS) of 20 or more were included in this study.
  • The first group underwent pTURP and for the second group diode laser ablation of prostate was done.
  • CONCLUSION: Diode laser ablation of prostate and pTURP, both improved significantly IPSS, PVR and Qmax.
  • [MeSH-major] Ablation Techniques / instrumentation. Carcinoma / surgery. Lasers, Semiconductor / therapeutic use. Palliative Care. Prostatic Neoplasms / surgery. Prostatism / surgery. Urinary Bladder Neck Obstruction / surgery
  • [MeSH-minor] Aged. Humans. Length of Stay. Male. Middle Aged. Operative Time. Time Factors. Transurethral Resection of Prostate. Urinary Catheterization. Urodynamics

  • Genetic Alliance. consumer health - Bladder cancer.
  • Genetic Alliance. consumer health - Prostate cancer.
  • MedlinePlus Health Information. consumer health - Palliative Care.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 25194077.001).
  • [ISSN] 1735-546X
  • [Journal-full-title] Urology journal
  • [ISO-abbreviation] Urol J
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Randomized Controlled Trial
  • [Publication-country] Iran
  •  go-up   go-down


2. Bell LJ, Eade T, Kneebone A, Hruby G, Alfieri F, Bromley R, Grimberg K, Barnes M, Booth JT: Initial experience with intra-fraction motion monitoring using Calypso guided volumetric modulated arc therapy for definitive prostate cancer treatment. J Med Radiat Sci; 2017 Mar;64(1):25-34
MedlinePlus Health Information. consumer health - Prostate Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Initial experience with intra-fraction motion monitoring using Calypso guided volumetric modulated arc therapy for definitive prostate cancer treatment.
  • INTRODUCTION: Accurate delivery of radiation while reducing dose to organs at risk is essential in prostate treatment.
  • Three patients had Calypso beacons inserted into their prostate.
  • Prostate rotation was largest in the pitch direction and 28 fractions exceeded the 10° tolerance.
  • [MeSH-major] Dose Fractionation. Movement. Prostatic Neoplasms / radiotherapy. Radiotherapy, Intensity-Modulated / methods

  • Genetic Alliance. consumer health - Prostate cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2017 The Authors. Journal of Medical Radiation Sciences published by Wiley Publishing Asia Pty Ltd on behalf of Australian Society of Medical Imaging and Radiation Therapy and New Zealand Institute of Medical Radiation Technology.
  • [Cites] Int J Radiat Oncol Biol Phys. 2010 Dec 1;78(5):1579-85 [20472357.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2007 Mar 15;67(4):1099-105 [17336216.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2007 Mar 15;67(4):1088-98 [17187940.001]
  • [Cites] Med Phys. 2014 Feb;41(2):020702 [24506591.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2015 Apr 1;91(5):1017-25 [25832692.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2013 Jul 1;86(3):477-83 [23523325.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2002 Aug 1;53(5):1097-105 [12128107.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2003 Jan 1;55(1):51-63 [12504036.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2006 Jun 1;65(2):528-34 [16690435.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):682-9 [17398026.001]
  • (PMID = 28263041.001).
  • [ISSN] 2051-3909
  • [Journal-full-title] Journal of medical radiation sciences
  • [ISO-abbreviation] J Med Radiat Sci
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; calypso / implementation / intra-fraction motion / prostate / radiation treatment
  •  go-up   go-down


3. Zakaria A, Al Share B, Kollepara S, Vakhariya C: External Beam Radiation and Brachytherapy for Prostate Cancer: Is It a Possible Trigger of Large Cell Neuroendocrine Carcinoma of the Urinary Bladder? Case Rep Oncol Med; 2017;2017:1853985

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] External Beam Radiation and Brachytherapy for Prostate Cancer: Is It a Possible Trigger of Large Cell Neuroendocrine Carcinoma of the Urinary Bladder?
  • Among those, large cell neuroendocrine carcinoma (LCNEC) is the least common, is more aggressive, and generally presents in an advanced stage with poor prognosis compared to transitional cell bladder carcinoma.
  • There is no standardized treatment regimen because of the rarity of the disease.
  • Herein, we present a case of 72-year-old male patient with previously treated prostate cancer, who received external beam radiation therapy and high dose brachytherapy, presenting with intermittent hematuria.
  • Cystoscopy and transurethral resection of bladder tumor (TURBT) were performed.
  • The histopathology and immunohistochemistry were consistent with large cell neuroendocrine carcinoma (LCNEC).
  • Further studies are required to proof the higher risk of neuroendocrine carcinoma of the bladder in patients treated with external beam radiation therapy and brachytherapy for prostate cancer.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Clin Pathol. 2007 Nov;128(5):733-9 [17951193.001]
  • [Cites] Clin Genitourin Cancer. 2013 Jun;11(2):73-7 [23266053.001]
  • [Cites] Arch Esp Urol. 2011 Mar;64(2):105-13 [21399243.001]
  • [Cites] Curr Urol. 2013 Feb;7(3):155-9 [24917779.001]
  • [Cites] Rare Tumors. 2014 Jan 23;6(1):5043 [24711904.001]
  • [Cites] Arch Pathol Lab Med. 2002 Oct;126(10):1229-32 [12296766.001]
  • [Cites] J Urol. 1998 May;159(5):1624-9 [9554367.001]
  • [Cites] Diagn Pathol. 2013 Feb 04;8:19 [23379295.001]
  • [Cites] Pathol Int. 2006 Nov;56(11):688-93 [17040293.001]
  • [Cites] Mod Pathol. 1998 Oct;11(10):1016-20 [9796733.001]
  • [Cites] J Urol. 2005 Jul;174(1):93-6 [15947585.001]
  • [Cites] Cancer. 2011 Dec 1;117(23):5325-33 [21567387.001]
  • [Cites] Cancer Treat Rev. 2006 Dec;32(8):588-93 [17008012.001]
  • [Cites] Cancer. 2005 Mar 15;103(6):1172-8 [15700264.001]
  • [Cites] J Urol. 2006 Aug;176(2):781 [16813945.001]
  • [Cites] Anticancer Res. 2008 Mar-Apr;28(2B):1369-72 [18505081.001]
  • [Cites] Int J Urol. 2008 Dec;15(12):1080-3 [19120517.001]
  • [Cites] Surg Neurol Int. 2011;2:84 [21748036.001]
  • (PMID = 28638669.001).
  • [ISSN] 2090-6706
  • [Journal-full-title] Case reports in oncological medicine
  • [ISO-abbreviation] Case Rep Oncol Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


Advertisement
4. Cadeddu JA: Re: Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Tissue in Patients with Localized Prostate Cancer: A Prospective Phase 1 Clinical Trial. J Urol; 2017 Jun;197(6):1457-1458

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Re: Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Tissue in Patients with Localized Prostate Cancer: A Prospective Phase 1 Clinical Trial.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28505900.001).
  • [ISSN] 1527-3792
  • [Journal-full-title] The Journal of urology
  • [ISO-abbreviation] J. Urol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


5. Jolnerovski M, Salleron J, Beckendorf V, Peiffert D, Baumann AS, Bernier V, Huger S, Marchesi V, Chira C: Intensity-modulated radiation therapy from 70Gy to 80Gy in prostate cancer: six- year outcomes and predictors of late toxicity. Radiat Oncol; 2017 Jun 16;12(1):99
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intensity-modulated radiation therapy from 70Gy to 80Gy in prostate cancer: six- year outcomes and predictors of late toxicity.
  • OBJECTIVE: To report grade ≥2 overall late rectal and urinary toxicities in patients (pts) with prostate cancer treated by intensity-modulated radiotherapy (IMRT) at 3 dose-levels.
  • The toxicity was described using the Common Terminology Criteria for Adverse Events (CTCAE) v4.0 scale.
  • Cox regression models addressed demographics, disease and dosimetry characteristics as potential predictors of late grade ≥2 toxicity after adjusting for other modifying factors.
  • For pts receiving 74 Gy, International Prostate Symptom Score (IPSS) at baseline ≥8 (HR = 2.40 [1.08; 5.35]) and dose ≥73Gy delivered in more than 2% of bladder (D2%) were found to be predictors of bladder toxicity (HR = 3.29 [1.36; 7.98]).

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Oncol (R Coll Radiol). 2016 Mar;28(3):227-8 [26482454.001]
  • [Cites] Radiother Oncol. 2014 Jan;110(1):104-9 [24246414.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2010 Jan 1;76(1):14-22 [19577865.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2011 Jul 15;80(4):1056-63 [21147514.001]
  • [Cites] Lancet Oncol. 2014 Apr;15(4):464-73 [24581940.001]
  • [Cites] J Urol. 2013 Aug;190(2):521-6 [23415964.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2010 Jul 1;77(3):773-83 [19836155.001]
  • [Cites] Radiother Oncol. 2009 Jul;92(1):42-7 [19356817.001]
  • [Cites] J Clin Oncol. 2005 Feb 20;23(6):1192-9 [15718316.001]
  • [Cites] Cancer. 2011 Apr 1;117(7):1429-37 [21425143.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2014 Apr 1;88(5):1074-84 [24661661.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):755-60 [19464123.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2011 Jul 15;80(4):1080-6 [20643513.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1997 Mar 15;37(5):1035-41 [9169810.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):686-92 [22795805.001]
  • [Cites] Res Rep Urol. 2013 Jan 14;5:29-37 [24400232.001]
  • [Cites] J Urol. 1992 Nov;148(5):1549-57; discussion 1564 [1279218.001]
  • [Cites] Radiother Oncol. 2012 May;103(2):252-5 [22521747.001]
  • [Cites] Strahlenther Onkol. 2003 May;179(5):320-7 [12740659.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):67-74 [17765406.001]
  • [Cites] J Clin Oncol. 2006 Oct 1;24(28):4581-6 [17008699.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2):384-90 [12957249.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):1130-7 [17881142.001]
  • [Cites] Strahlenther Onkol. 2009 Feb;185(2):94-100 [19240995.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):965-74 [16798415.001]
  • [Cites] Urology. 2005 Sep;66(3):566-70 [16140079.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2006 Oct 1;66(2):430-8 [16904846.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2016 Jun 1;95(2):680-9 [27055398.001]
  • [Cites] Radiother Oncol. 2007 Feb;82(2):160-6 [17222931.001]
  • [Cites] Eur Urol. 2008 Jun;53(6):1172-9 [18222596.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):1028-33 [18280056.001]
  • [Cites] JAMA. 2005 Sep 14;294(10):1233-9 [16160131.001]
  • [Cites] J Urol. 2002 Jan;167(1):123-6 [11743288.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):235-41 [21163587.001]
  • [Cites] Can J Urol. 2012 Aug;19(4):6373-80 [22892261.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2008 Jul 1;71(3):784-94 [18191332.001]
  • [Cites] JAMA. 1998 Sep 16;280(11):969-74 [9749478.001]
  • (PMID = 28622770.001).
  • [ISSN] 1748-717X
  • [Journal-full-title] Radiation oncology (London, England)
  • [ISO-abbreviation] Radiat Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Intensity-modulated radiation therapy / Prognostic factors / Prostate cancer / Rectal and urinary toxicity
  •  go-up   go-down


6. Hosni A, Rosewall T, Craig T, Kong V, Bayley A, Berlin A, Bristow R, Catton C, Warde P, Chung P: The effect of bowel preparation regime on interfraction rectal filling variation during image guided radiotherapy for prostate cancer. Radiat Oncol; 2017 Mar 09;12(1):50
MedlinePlus Health Information. consumer health - Prostate Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The effect of bowel preparation regime on interfraction rectal filling variation during image guided radiotherapy for prostate cancer.
  • BACKGROUND: This study aimed to investigate the tolerability and impact of milk of magnesia (MoM) on interfraction rectal filling during prostate cancer radiotherapy.
  • METHODS: Two groups were retrospectively identified, each consisting of 40 patients with prostate cancer treated with radiotherapy to prostate+/-seminal vesicles, with daily image-guidance in 78Gy/39fractions/8 weeks.
  • [MeSH-major] Artifacts. Intestine, Small / physiology. Prostatic Neoplasms / radiotherapy. Radiotherapy, Image-Guided / methods

  • Genetic Alliance. consumer health - Rectal Cancer.
  • Genetic Alliance. consumer health - Prostate cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1611-21 [15590193.001]
  • [Cites] Eur Urol. 2011 Dec;60(6):1133-9 [21889832.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):125-9 [22330997.001]
  • [Cites] Radiother Oncol. 2010 Jun;95(3):277-82 [20451274.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2008 Oct 1;72 (2):456-66 [18374517.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):1072-8 [19783378.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2006 Jun 1;65(2):548-53 [16545919.001]
  • [Cites] Strahlenther Onkol. 2014 Aug;190(8):758-61 [24760248.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1999 Jun 1;44(3):525-33 [10348281.001]
  • [Cites] Radiother Oncol. 2011 Dec;101(3):471-8 [21903283.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):646-50 [24054874.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2007 Apr 1;67(5):1418-24 [17241751.001]
  • [Cites] Radiother Oncol. 1999 Feb;50(2):225-34 [10368047.001]
  • [Cites] Jpn J Radiol. 2009 Jun;27(5):205-12 [19554413.001]
  • [Cites] JAMA. 1997 May 14;277(18):1445-51 [9145716.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):1279-86 [18572088.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):965-73 [15989996.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1405-18 [19616743.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):653-60 [22099039.001]
  • [Cites] Acta Oncol. 2014 Apr;53(4):569-71 [24237391.001]
  • (PMID = 28279179.001).
  • [ISSN] 1748-717X
  • [Journal-full-title] Radiation oncology (London, England)
  • [ISO-abbreviation] Radiat Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Laxatives
  • [Keywords] NOTNLM ; Bowel preparation / Laxative / Prostate cancer / Radiotherapy / Rectum
  •  go-up   go-down


7. Shahriari M, Dehghan M, Pahlavanzadeh S, Hazini A: Effects of progressive muscle relaxation, guided imagery and deep diaphragmatic breathing on quality of life in elderly with breast or prostate cancer. J Educ Health Promot; 2017;6:1

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Effects of progressive muscle relaxation, guided imagery and deep diaphragmatic breathing on quality of life in elderly with breast or prostate cancer.
  • BACKGROUND AND OBJECTIVES: Due to the increasing number of elderly and an increase in the number of cases of cancer by age, cancer is a common problem in the elderly.
  • For elderly patients with cancer, the disease and its treatment can have long-term negative effects on their quality of life (QoL).
  • The purpose of this study was to evaluate the effect of progressive muscle relaxation, body image and deep diaphragmatic breathing on the QoL in the elderly with cancer.
  • MATERIALS AND METHODS: This study was a randomized controlled trial in which 50 elderly patients with breast or prostate cancer were randomized into study and control groups.
  • European Organization for Research and Treatment of Cancer and QoL Questionnaire-Core questionnaires was completed before, after and 6 weeks after the intervention for the patients in both groups simultaneously.
  • CONCLUSIONS: The findings indicated that concurrent application of progressive muscle relaxation, guided imagery, and deep diaphragmatic breathing would improve QoL in the elderly with breast or prostate cancer.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nurs Forum. 2006 Apr-Jun;41(2):60-77 [16669984.001]
  • [Cites] Indian J Med Res. 2009 May;129(5):603-8 [19675392.001]
  • [Cites] J Clin Oncol. 2003 May 15;21(10):1944-51 [12743147.001]
  • [Cites] Psychooncology. 2007 Nov;16(11):971-9 [17311247.001]
  • [Cites] Complement Ther Clin Pract. 2008 Aug;14(3):185-94 [18640630.001]
  • [Cites] J Child Psychol Psychiatry. 2004 Oct;45(7):1199-208 [15335340.001]
  • [Cites] CA Cancer J Clin. 2013 Jan;63(1):11-30 [23335087.001]
  • [Cites] Support Care Cancer. 2005 Oct;13(10):826-33 [15856335.001]
  • [Cites] Psychooncology. 2003 Apr-May;12(3):254-66 [12673809.001]
  • [Cites] Cancer Nurs. 2002 Dec;25(6):432-5 [12464834.001]
  • [Cites] J Pain Symptom Manage. 2010 Jan;39(1):126-38 [19900778.001]
  • [Cites] Ann Oncol. 2010 May;21 Suppl 3:iii83-89 [20427365.001]
  • [Cites] Support Care Cancer. 2002 Apr;10(3):237-46 [11904789.001]
  • [Cites] Cancer. 2009 Sep 15;115(18 Suppl):4283-97 [19731348.001]
  • [Cites] Support Cancer Ther. 2007 Sep 1;4(4):247-50 [18632524.001]
  • (PMID = 28546966.001).
  • [ISSN] 2277-9531
  • [Journal-full-title] Journal of education and health promotion
  • [ISO-abbreviation] J Educ Health Promot
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Keywords] NOTNLM ; Cancer / diaphragmatic breathing / elderly / guided imagery / progressive muscle relaxation / quality of life
  •  go-up   go-down


8. Spahn M, Morlacco A, Boxler S, Joniau S, Briganti A, Montorsi F, Gontero P, Bader P, Frohneberg D, van Poppel H, Karnes RJ, European Multicenter Prostate Cancer Clinical and Translational Research Group (EMPAcT): Outcome predictors of radical cystectomy in patients with cT4 prostate cancer: a multi-institutional study of 62 patients. BJU Int; 2017 Feb 20;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Outcome predictors of radical cystectomy in patients with cT4 prostate cancer: a multi-institutional study of 62 patients.
  • OBJECTIVES: To identify which patients with macroscopic bladder-infiltrating T4 prostate cancer (PCa) might have favourable outcomes when treated with radical cystectomy (RC).
  • Although recurrences are probable, these do not necessarily translate into cancer-specific death.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2017 The Authors BJU International © 2017 BJU International Published by John Wiley & Sons Ltd.
  • (PMID = 28220605.001).
  • [ISSN] 1464-410X
  • [Journal-full-title] BJU international
  • [ISO-abbreviation] BJU Int.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; #PCSM / #ProstateCancer / #uroonc / cystectomy / high-risk prostate cancer / locally advanced prostate cancer / multimodality treatment / surgery
  •  go-up   go-down


9. Imm KR, Williams F, Housten AJ, Colditz GA, Drake BF, Gilbert KL, Yang L: African American prostate cancer survivorship: Exploring the role of social support in quality of life after radical prostatectomy. J Psychosoc Oncol; 2017 Apr 11;:1-15

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] African American prostate cancer survivorship: Exploring the role of social support in quality of life after radical prostatectomy.
  • PURPOSE: The aim of this study was to explore the African American prostate cancer survivorship experience following radical prostatectomy and factors contributing to quality of life during survival.
  • DESIGN: African American men who were part of a larger prostate cancer cohort were invited to participate in a focus group.
  • Emergent themes included views of prostate cancer in the African American community, perceptions of normalcy, emotional side effects following radical prostatectomy, and social support involvement and impact during recovery.
  • CONCLUSIONS: Previous findings suggest that African American men may experience more distress than Caucasian men when facing typical prostate cancer side effects.
  • Traditional masculine role norms and negative perceptions of "disease disclosure" in the African American community could be contributing to the distress reported by some in this study.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28398149.001).
  • [ISSN] 1540-7586
  • [Journal-full-title] Journal of psychosocial oncology
  • [ISO-abbreviation] J Psychosoc Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; African American / prostate cancer / quality of life / radical prostatectomy / social support
  •  go-up   go-down


10. Onal C, Dolek Y, Ozdemir Y: The impact of androgen deprivation therapy on setup errors during external beam radiation therapy for prostate cancer. Strahlenther Onkol; 2017 Jun;193(6):472-482

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The impact of androgen deprivation therapy on setup errors during external beam radiation therapy for prostate cancer.
  • [Transliterated title] Einfluss der Androgendeprivationstherapie auf Konfigurationsfehler bei der externen Strahlentherapie des Prostatakarzinoms.
  • PURPOSE: To determine whether setup errors during external beam radiation therapy (RT) for prostate cancer are influenced by the combination of androgen deprivation treatment (ADT) and RT.
  • MATERIALS AND METHODS: Data from 175 patients treated for prostate cancer were retrospectively analyzed.
  • Mean prostate shifts and standard deviations (SD) were calculated and pooled to obtain mean or group systematic error (M), SD of systematic error (Σ), and SD of random error (σ).
  • RESULTS: No significant differences were observed in prostate shifts in any direction between the groups.
  • A significant positive correlation was observed between prostate volume and the z‑direction prostate shift (r = 0.19, p = 0.04), regardless of ADT group, but not between volume and x‑ or y‑direction shifts (r = 0.04, p = 0.7; r = 0.03, p = 0.7).
  • Prostate volume was significantly correlated with shifts in the anterior-posterior direction only.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28409246.001).
  • [ISSN] 1439-099X
  • [Journal-full-title] Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
  • [ISO-abbreviation] Strahlenther Onkol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Keywords] NOTNLM ; Fiducial markers / Organs at risk / Prostate-specific antigen / Radiotherapy, image-guided / Toxicity
  •  go-up   go-down






Advertisement